Krishna Institute of Medical Sciences

645.80
+3.55
(0.55%)
ann
There are 2 new updates from the company22 hours ago
Viewcross
right
Market Cap
25,840.97 Cr
EPS
38.75
PE Ratio
73.54
Dividend Yield
0.00 %
52 Week High
674.30
52 Week Low
350.00
PB Ratio
12.79
Debt to Equity
0.58
Sector
Hospitals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from9 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy+88.89 %
+88.89 %
Hold+11.11 %
+11.11 %
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,163.15 1,13,073.54 105.07 5,584.10 18.77 1,058 -17.46 65.37
6,646.05 95,560.00 72.60 19,165.50 14.74 917 49.14 62.72
647.40 48,875.99 62.50 6,931.20 8.99 645 89.49 58.60
1,257.70 33,780.24 65.17 2,759.20 25.09 326 15.71 56.75
1,652.60 33,772.67 43.57 5,093.40 10.96 790 2.66 68.00
645.80 25,840.97 73.54 2,511.20 12.94 336 20.76 70.04
441.00 22,028.53 83.02 3,723.70 22.85 205 -69.22 52.98
1,342.15 13,629.76 57.92 1,334.00 10.76 218 10.06 57.97
1,699.90 11,145.57 56.93 1,095.50 21.32 177 20.14 72.89
530.80 7,399.50 136.75 1,929.10 12.97 41 129.41 67.81
Growth Rate
Revenue Growth
12.94 %
Net Income Growth
-8.15 %
Cash Flow Change
20.60 %
ROE
-14.99 %
ROCE
-23.55 %
EBITDA Margin (Avg.)
-8.15 %

Quarterly Financial Results

Quarterly Financials
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
268
206
411
361
363
478
417
398
388
501
588
569
581
609
655
609
638
693
782
790
Expenses
203
165
268
268
258
330
283
264
259
358
412
411
413
449
475
459
475
509
559
585
EBITDA
65
40
143
93
105
148
134
134
129
143
177
158
168
160
180
150
163
184
223
205
Operating Profit %
24 %
18 %
34 %
26 %
28 %
30 %
31 %
33 %
31 %
28 %
27 %
27 %
28 %
26 %
27 %
24 %
25 %
26 %
28 %
24 %
Depreciation
17
17
16
20
17
17
18
19
19
29
31
33
35
32
33
35
46
39
41
45
Interest
10
9
7
9
7
6
3
3
4
6
8
12
5
9
9
12
16
18
20
26
Profit Before Tax
38
14
120
65
81
125
113
112
107
107
138
113
127
119
139
102
100
127
162
135
Tax
10
5
29
17
22
33
29
28
24
28
31
31
29
32
37
26
29
32
42
42
Net Profit
28
9
90
48
59
92
84
84
83
79
106
82
99
87
101
77
72
95
121
93
EPS in ₹
3.72
1.49
11.21
6.55
7.72
11.48
10.34
10.14
10.08
8.74
12.14
9.49
11.65
10.10
11.50
8.98
8.18
10.82
2.68
2.22

Balance Sheet

Balance Sheet
2018
2019
2020
2021
2022
2023
2024
Total Assets
958
1,118
1,196
1,436
1,907
2,941
3,852
Fixed Assets
755
863
916
931
1,005
1,766
2,434
Current Assets
156
174
220
451
393
478
547
Capital Work in Progress
0
0
2
9
21
477
600
Investments
0
0
0
0
333
68
157
Other Assets
203
254
278
496
549
630
661
Total Liabilities
958
1,118
1,196
1,436
1,907
2,941
3,852
Current Liabilities
749
201
219
278
215
297
452
Non Current Liabilities
347
351
366
282
282
707
1,307
Total Equity
-138
566
611
876
1,411
1,938
2,093
Reserve & Surplus
-209
466
523
786
1,307
1,590
1,748
Share Capital
50
75
75
78
80
80
80

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
5
-11
5
3
-3
33
12
-27
36
-15
Investing Activities
-71
-41
-100
-64
-110
-125
-354
-412
-416
-753
Operating Activities
64
95
82
106
134
202
356
324
432
521
Financing Activities
12
-66
24
-39
-27
-44
10
61
20
217

Share Holding

% Holding
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.84 %
38.82 %
38.82 %
38.82 %
38.82 %
38.82 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
8.61 %
8.61 %
0.00 %
14.25 %
0.00 %
16.73 %
17.84 %
15.85 %
15.68 %
DIIs
13.81 %
16.11 %
18.35 %
18.49 %
20.46 %
27.98 %
28.32 %
29.76 %
33.03 %
34.80 %
31.63 %
33.13 %
32.12 %
32.30 %
32.05 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
13.14 %
14.23 %
13.38 %
12.88 %
11.81 %
11.50 %
11.32 %
11.10 %
11.22 %
11.15 %
10.84 %
10.73 %
10.61 %
10.55 %
10.97 %
Others
34.21 %
30.82 %
29.42 %
29.79 %
28.88 %
21.68 %
12.92 %
11.69 %
16.91 %
0.96 %
18.70 %
0.59 %
0.61 %
2.48 %
2.48 %
No of Share Holders
0
267
86,389
74,355
73,664
70,795
67,735
60,980
65,449
66,957
71,014
69,092
69,063
77,617
95,468

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Closure of Trading Window
18 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
22 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
5 days ago
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
6 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Mar 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Mar 05, 2025
Krishna Institute Of Medical Sciences Limited Has Informed The Exchange About Intimation Of The Order Received From The Regional Director (South-East Region) Confirming The Scheme Of Amalgamation U/S 233 Of Companies Act 2013 For The Merger Of Rajyalakshm
Mar 02, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 22, 2025
KIMS Entered Into An Operations And Management Agreement With Splendid Hospitals Private Limited Hyderabad Telangana.
Feb 20, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 17, 2025
KIMS Entered Into An Operations And Management Agreement With Ushahkal Abhinav Institute Of Medical Sciences (UAIMS Hospital) Sangli Maharashtra.
Feb 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 15, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Feb 14, 2025
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Feb 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Feb 06, 2025
Announcement under Regulation 30 (LODR)-Investor Presentation
Feb 06, 2025
Integrated Filing (Financial)
Feb 06, 2025
Quarterly Result_31St December 2024
Feb 06, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 06â„¢ February 2025 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.
Feb 06, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 31, 2025
KIMS Swastha Private Limited (The KIMS) A Wholly-Owned Subsidiary Of Krishna Institute Of Medical Sciences Limited Has Entered Into An Agreement On 27Th January 2025 With Valiyath Institute Of Medical
Jan 28, 2025
Board Meeting Intimation for The Approval Of The Unaudited (Standalone & Consolidated) Financial Results Of The Company For The 03Rd Quarter And Nine Months Ended December 31 2024
Jan 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dec 10, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dec 07, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dec 06, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Dec 06, 2024
Announcement under Regulation 30 (LODR)-Acquisition
Dec 05, 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Nov 29, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 29, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 29, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 27, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 26, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Nov 15, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 14, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 14, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Nov 11, 2024
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 10, 2024
Announcement under Regulation 30 (LODR)-Investor Presentation
Nov 09, 2024
KIMS Entered Into An Operations And Management Agreement With Insignia Healthcare Private Limited.
Nov 09, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Nov 09, 2024

Technical Indicators

RSI(14)
Neutral
70.04
ATR(14)
Volatile
27.13
STOCH(9,6)
Overbought
90.74
STOCH RSI(14)
Overbought
97.63
MACD(12,26)
Bullish
13.94
ADX(14)
Strong Trend
30.22
UO(9)
Bearish
71.27
ROC(12)
Uptrend And Accelerating
26.32
WillR(14)
Overbought
-2.87

About Krishna Institute of Medical Sciences

Krishna Institute of Medical Sciences Limited (KIMS) is an Indian healthcare company operating 12 multispecialty hospitals under the KIMS Hospitals brand. With over 4,000 beds, KIMS provides tertiary and quaternary healthcare services across more than 40 specialties and super specialties. The company's network includes hospitals in Telangana, Andhra Pradesh, and Maharashtra. KIMS offers medical education programs through affiliations with state medical boards and universities. The company's hospitals are equipped with advanced medical technology, including robotic surgical systems and specialized imaging equipment. KIMS has received various accreditations and awards for its healthcare services and facilities. In recent developments, Sunshine Hospitals became a subsidiary of KIMS in 2022, and the company opened a new gastroenterology unit in Vizag.
Listing Date
28 Jun, 2021(3 Years, 25 days)
Chairperson NameBhaskara Rao Bollineni